Seed and Series A investor—the first specialist fund focused solely on treating aging as a disease—led by Laura Deming; portfolio ventures have raised >$1B and produced multiple IPOs. The firm continues to build its presence across the venture capital landscape.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Backs early-phase life sciences businesses, often backing founders when they are no more than an idea.
Centered on relocating early-phase companies—especially from Latin America—to Tulsa via investments and coordinated city-building programs, with growth measured by financial returns and local employment outcomes. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Venture studio and fund that co‑incubates with LifePoint executives, giving startup ventures direct access to a $50B+ health system for pilot deployment, real‑world validation, and underserved population focus. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Nascent-stage investor spanning service-heavy care delivery and deep neuro/bio/AR frontier tech, delivering specialized neuro+AI+delivery expertise that bridges physical clinics and cutting-edge technologies. With a disciplined investment approach, the team drives value for both founders and investors.
Seed and early-phase investor that creates and funds biotech young companies, emphasizing company creation. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Salt Lake City–based fund backing founders addressing underserved populations across 49 states, using a pedigree-penalizing scorecard and a 6+ month startup academy of specialist coaches to reach overlooked geographies. With a disciplined investment approach, the team drives value for both founders and investors.
